CORREVIO PHARMA CORP. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
+1.06% | +2.41% |
| 2020 | Mark Corrigan Departs as CEO from Correvio Pharma Corp | CI |
| 2020 | Justin Renz, CFO Departs from Correvio Pharma Corp | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 78.51B | ||||||
| 9B | ||||||
| 4.96B | - | - | ||||
| 4.84B | ||||||
| 3.72B |
